The first is cellular therapies.

We have effective therapies now.

How about more targeted therapies for cancer?

The therapies will be improving faster than the remaining imperfections in the therapies are catching up with us.

There has, however, been no concomitant increase in the resources available to police forces.

We'd like to get therapies better and more effective.

With my own healthcare problems, I've taken drug therapies,

All of this understanding is leading to new strategies and therapies.

Stem cell therapies may one day reduce the need for donor organs.

That is essentially what we've been doing for 50 years in immune therapies.

I'm saying that the rate of improvement of those therapies will be enough.

These are some of the questions that are at the center of my exploration on the nature of erotic desire and its concomitant dilemmas in modern love.

But still ways to go to get stem cells into patients, in terms of actual therapies for organs.

Physical therapies can be done, not only in the orthopedic center, but also in the houses of the people.

That in fact, the people who are young enough to benefit from these first therapies that give this moderate amount of life extension, even though those people are already middle aged when the therapies arrive, will be at some sort of cusp.

We can't just say, Well, if they're young enough to benefit from these therapies, then they'll live 30 years longer.

If you're already 100, or even if you're 80 and an average 80 year old, we probably can't do a lot for you with these therapies, because you're too close to death's door for the really initial, experimental therapies to be good enough for you.

So, in other words, we add two years we treble their remaining lifespan, starting from the point that we started the therapies.

A high death rate will, of course, arise from simply rejecting these therapies, in favor of carrying on having a lot of kids.

My father and my grandfather were always looking for the newest thing in alternative or traditional therapies for PH, but after six months,

Sometimes they're therapies that remove some of the signs that are causing the problem and have been used in the process of the disease.

There are of course plenty of studies going on around the world which are more indirectly focus on the eventual hopeful development of anti aging therapies

And then we do a whole bunch of stuff to them, and with those therapies, we get them to live, on average, to their fifth birthday.

Because, you know, most people, when they hear that I predict that a lot of people alive today are going to live to 1,000 or more, they think that I'm saying that we're going to invent therapies in the next few decades that are so thoroughly eliminating aging that those therapies will let us live to 1,000 or more.

Now, obviously the jury is out on many of these complementary therapies, and I personally doubt that the coffee enema will ever, you know, gain mainstream approval.

What would that actually mean for how long people of various ages today or equivalently, of various ages at the time that these therapies arrive would actually live?

We will always have the possibility of dying from old age even when this therapies exist, just as today we have the possibility of dying of polio or tuberculosis.

Essentially all work bio gerontology within the study of understanding aging, it's with an eventual hope that our understanding will lead us to be able to develop future therapies.

If we vacillate, hesitate, and do not actually develop these therapies, then we are condemning a whole cohort of people who would have been young enough and healthy enough to benefit from those therapies, but will not be, because we haven't developed them as quickly as we could we'll be denying those people an indefinite life span, and I consider that that is immoral.

And they were able to change therapies, including disabling the device and this is with a real, commercial, off the shelf device simply by performing reverse engineering and sending wireless signals to it.

She gave a shot of her chloroquine what I learned was the chloroquine then gave her some it must have been a re hydration and some other therapies, and put us in a corner.

So, these trajectories here are basically how we would expect people to live, in terms of remaining life expectancy, as measured by their health, for given ages that they were at the time that these therapies arrive.

The Foundation that I run the Methuselah Foundation, in which I'm the chairman and the chief science office there, it's probably the main one that really focusing on the development of future therapies that will really combat aging.

But starting in 2004, when antiangiogenic therapies first became available, you can see that there has been a 70 to 100 percent improvement in survival for people with kidney cancer, multiple myeloma, colorectal cancer, and gastrointestinal stromal tumors.

I was also doing cancer research, immune based therapies for melanoma, to be specific, and in that world I was actually taught to question everything, to challenge all assumptions and hold them to the highest possible scientific standards.

And if we can get in at the bottom and understand the genetics, we'll have a window on the way the disease works, and a whole new way about thinking about disease therapies and preventative treatment and so on.

So this is a genuine conclusion that I come to, that the first 150 year old we don't know how old that person is today, because we don't know how long it's going to take to get these first generation therapies.

But we will not have the necessity of dying of old age because these therapies would be able to postpone the accumulating molecular and cellular damage of aging indefinitelly, just in the same way that classic cars do not actually die at all.

We're looking at ways to make bees healthier through vaccines, through yogurt, like probiotics, and other types of therapies in ways that can be fed orally to bees, and this process is so easy, even a 7 year old can do it.

I went back to school, in chemistry, with the idea that perhaps by learning the trade of discovery chemistry and approaching it in the context of this brave new world of the open source, the crowd source, the collaborative network that we have access to within academia, that we might more quickly bring powerful and targeted therapies to our patients.

And so thinking about the models that we've just discussed, you can see, going forward, that tissue engineering is actually poised to help revolutionize drug screening at every single step of the path disease models making for better drug formulations, massively parallel human tissue models helping to revolutionize lab testing, reduce animal testing and human testing in clinical trials, and individualized therapies that disrupt what we even consider to be a market at all.